Human growth hormone (somatropin) in adults with growth hormone deficiency

  • Technology appraisal guidance
  • TA64
  • Published: 

Human growth hormone - update

The Appraisal Committee met on 23rd January 2003 to consider the clinical and cost effectiveness of HGH in adults following the decision of the appeal panel.

At the meeting, the Committee agreed to issue an Appraisal Consultation Document (ACD) to consultees for comment and to meet again on 26th March 2003 to review the ACD in the light of the comments received.

A Final Appraisal Determination will be produced after the meeting on 26th March.

This page was last updated: 30 March 2010